Outcomes in pediatric cardiac transplantation with a positive HLA cross-match

Marc E. Richmond, Daphne T. Hsu, Ralph S. Mosca, Jonathan Chen, Jan M. Quaegebeur, Linda J. Addonizio, Jacqueline M. Lamour

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previous studies have shown poor outcomes in pediatric heart transplant recipients with a high PRA or a positive direct donor-recipient cross-match. This study describes outcomes in patients with a positive cross-match at a large pediatric program. Pediatric heart transplant patients at a large single center between January 1993 and July 2009 were reviewed; those with cross-match data were analyzed. Cross-match data were available in 242/262 (92.4%) patients. Indications for transplant were cardiomyopathy (58%), CHD (32%), and retransplant (7%). PRA was ≥10% in 31/213 (14.6%) patients. A retrospective cross-match was positive in 17/31 (55%) patients with PRA ≥10% and 0/182 with PRA <10%. In positive cross-match patients, rejection frequency in the first year post-transplant was higher than negative cross-match patients (1.69 vs. 0.96 episodes/pt year, p = 0.014). There was no difference in rejection frequency after the first year post-transplant (0.18 vs. 0.12 episodes/pt year, p = 0.14). Overall survival was not significantly different between the groups with a median follow-up time of 4.5 yr. Heart transplantation in patients with a positive cross-match may result in good medium-term survival but a higher frequency of early rejection. Further investigation is warranted to define which patients with a positive cross-match will do poorly.

Original languageEnglish (US)
Pages (from-to)29-35
Number of pages7
JournalPediatric Transplantation
Volume16
Issue number1
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Heart Transplantation
Pediatrics
Transplants
Survival
Cardiomyopathies
Outcome Assessment (Health Care)
Tissue Donors

Keywords

  • anti-HLA antibody
  • HLA
  • outcome
  • pediatric heart transplant
  • survival

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Outcomes in pediatric cardiac transplantation with a positive HLA cross-match. / Richmond, Marc E.; Hsu, Daphne T.; Mosca, Ralph S.; Chen, Jonathan; Quaegebeur, Jan M.; Addonizio, Linda J.; Lamour, Jacqueline M.

In: Pediatric Transplantation, Vol. 16, No. 1, 02.2012, p. 29-35.

Research output: Contribution to journalArticle

Richmond, Marc E. ; Hsu, Daphne T. ; Mosca, Ralph S. ; Chen, Jonathan ; Quaegebeur, Jan M. ; Addonizio, Linda J. ; Lamour, Jacqueline M. / Outcomes in pediatric cardiac transplantation with a positive HLA cross-match. In: Pediatric Transplantation. 2012 ; Vol. 16, No. 1. pp. 29-35.
@article{83135cee19a642ccbb558e1e5f0b431c,
title = "Outcomes in pediatric cardiac transplantation with a positive HLA cross-match",
abstract = "Previous studies have shown poor outcomes in pediatric heart transplant recipients with a high PRA or a positive direct donor-recipient cross-match. This study describes outcomes in patients with a positive cross-match at a large pediatric program. Pediatric heart transplant patients at a large single center between January 1993 and July 2009 were reviewed; those with cross-match data were analyzed. Cross-match data were available in 242/262 (92.4{\%}) patients. Indications for transplant were cardiomyopathy (58{\%}), CHD (32{\%}), and retransplant (7{\%}). PRA was ≥10{\%} in 31/213 (14.6{\%}) patients. A retrospective cross-match was positive in 17/31 (55{\%}) patients with PRA ≥10{\%} and 0/182 with PRA <10{\%}. In positive cross-match patients, rejection frequency in the first year post-transplant was higher than negative cross-match patients (1.69 vs. 0.96 episodes/pt year, p = 0.014). There was no difference in rejection frequency after the first year post-transplant (0.18 vs. 0.12 episodes/pt year, p = 0.14). Overall survival was not significantly different between the groups with a median follow-up time of 4.5 yr. Heart transplantation in patients with a positive cross-match may result in good medium-term survival but a higher frequency of early rejection. Further investigation is warranted to define which patients with a positive cross-match will do poorly.",
keywords = "anti-HLA antibody, HLA, outcome, pediatric heart transplant, survival",
author = "Richmond, {Marc E.} and Hsu, {Daphne T.} and Mosca, {Ralph S.} and Jonathan Chen and Quaegebeur, {Jan M.} and Addonizio, {Linda J.} and Lamour, {Jacqueline M.}",
year = "2012",
month = "2",
doi = "10.1111/j.1399-3046.2011.01555.x",
language = "English (US)",
volume = "16",
pages = "29--35",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Outcomes in pediatric cardiac transplantation with a positive HLA cross-match

AU - Richmond, Marc E.

AU - Hsu, Daphne T.

AU - Mosca, Ralph S.

AU - Chen, Jonathan

AU - Quaegebeur, Jan M.

AU - Addonizio, Linda J.

AU - Lamour, Jacqueline M.

PY - 2012/2

Y1 - 2012/2

N2 - Previous studies have shown poor outcomes in pediatric heart transplant recipients with a high PRA or a positive direct donor-recipient cross-match. This study describes outcomes in patients with a positive cross-match at a large pediatric program. Pediatric heart transplant patients at a large single center between January 1993 and July 2009 were reviewed; those with cross-match data were analyzed. Cross-match data were available in 242/262 (92.4%) patients. Indications for transplant were cardiomyopathy (58%), CHD (32%), and retransplant (7%). PRA was ≥10% in 31/213 (14.6%) patients. A retrospective cross-match was positive in 17/31 (55%) patients with PRA ≥10% and 0/182 with PRA <10%. In positive cross-match patients, rejection frequency in the first year post-transplant was higher than negative cross-match patients (1.69 vs. 0.96 episodes/pt year, p = 0.014). There was no difference in rejection frequency after the first year post-transplant (0.18 vs. 0.12 episodes/pt year, p = 0.14). Overall survival was not significantly different between the groups with a median follow-up time of 4.5 yr. Heart transplantation in patients with a positive cross-match may result in good medium-term survival but a higher frequency of early rejection. Further investigation is warranted to define which patients with a positive cross-match will do poorly.

AB - Previous studies have shown poor outcomes in pediatric heart transplant recipients with a high PRA or a positive direct donor-recipient cross-match. This study describes outcomes in patients with a positive cross-match at a large pediatric program. Pediatric heart transplant patients at a large single center between January 1993 and July 2009 were reviewed; those with cross-match data were analyzed. Cross-match data were available in 242/262 (92.4%) patients. Indications for transplant were cardiomyopathy (58%), CHD (32%), and retransplant (7%). PRA was ≥10% in 31/213 (14.6%) patients. A retrospective cross-match was positive in 17/31 (55%) patients with PRA ≥10% and 0/182 with PRA <10%. In positive cross-match patients, rejection frequency in the first year post-transplant was higher than negative cross-match patients (1.69 vs. 0.96 episodes/pt year, p = 0.014). There was no difference in rejection frequency after the first year post-transplant (0.18 vs. 0.12 episodes/pt year, p = 0.14). Overall survival was not significantly different between the groups with a median follow-up time of 4.5 yr. Heart transplantation in patients with a positive cross-match may result in good medium-term survival but a higher frequency of early rejection. Further investigation is warranted to define which patients with a positive cross-match will do poorly.

KW - anti-HLA antibody

KW - HLA

KW - outcome

KW - pediatric heart transplant

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84856012185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856012185&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2011.01555.x

DO - 10.1111/j.1399-3046.2011.01555.x

M3 - Article

VL - 16

SP - 29

EP - 35

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 1

ER -